Lipoic acid downmodulates CD4 from human T lymphocytes by dissociation of p56Lck

Biochemical and Biophysical Research Communications

Volumn 344, Issue 3, 2006, Pages 963-971

  Marracci, Gail H ^a,b   Marquardt, Whitney E ^a   Strehlow, Adrienne ^a   McKeon, Gabriel P ^a   Gross, Jonathan ^a   Buck, David C ^a,b   Kozell, Laura B ^a,b   Bourdette, Dennis N ^a,b  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

CD4; Lipoic acid; p56Lck

Indexed keywords

CD4 ANTIGEN; PROTEIN P56; THIOCTIC ACID; ANTIOXIDANT; PROTEIN KINASE LCK;

ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENDOCYTOSIS; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LEUKEMIA CELL LINE; MULTIPLE SCLEROSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; CELL CULTURE; DOSE RESPONSE; DRUG EFFECT; METABOLISM; MONONUCLEAR CELL; PHYSIOLOGY; PROTEIN BINDING;

ANTIGENS, CD4; ANTIOXIDANTS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; HUMANS; JURKAT CELLS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); PROTEIN BINDING; T-LYMPHOCYTES; THIOCTIC ACID;

EID: 33745249560     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.03.172     Document Type: Article

References (49)

1. Martin R., McFarland H.F., and McFarlin D.E. Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10 (1992) 153
2. Trapp B.D., Peterson J., Ransohoff R.M., Rudick R., Mork S., and Bo L. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338 (1998) 278
3. Schmidt S. Candidate autoantigens in multiple sclerosis. Mult. Scler. 5 (1999) 147
4. Whitham R., Bourdette D., Hashim G., Herndon R., Ilg R., Vandenbark A., and Offner H. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis. J. Immunol. 146 (1991) 101
5. Linington C., Berger T., Perry L., Weerth S., Hinze-Selch D., Zhang Y., Lu H.C., Lassmann H., and Wekerle H. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur. J. Immunol. 23 (1993) 1364
6. Genain C.P., Cannella B., Hauser S.L., and Raine C.S. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat. Med. 5 (1999) 170
7. + T cells. Eur. J. Immunol. 24 (1994) 2250
8. Edling A.E., Choksi S., Huang Z., and Korngold R. An organic CD4 inhibitor reduces the clinical and pathological symptoms of acute experimental allergic encephalomyelitis. J. Autoimmun. 18 (2002) 169
9. Barclay A.N., Brady R.L., Davis S.J., and Lange G. CD4 and the immunoglobulin superfamily. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 342 (1993) 7
10. Carr S., Hemling M., Folena-Wasserman G., Sweet R., Anumula K., Barr J., Huddleston M., and Taylor P. Protein and carbohydrate structural analysis of a recombinant soluble CD4 receptor by mass spectrometry [published erratum appears in J. Biol. Chem. 265 (6) (1990) 3585]. J. Biol. Chem. 264 (1989) 21286
11. Konig R., Shen X., and Germain R. Involvement of both major histocompatibility complex class II alpha and beta chains in CD4 function indicates a role for ordered oligomerization in T cell activation. J. Exp. Med. 182 (1995) 779
12. Madrenas J., Chau L.A., Smith J., Bluestone J.A., and Germain R.N. The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/partial agonist properties of peptide-MHC molecule ligands. J. Exp. Med. 185 (1997) 219
13. Fragoso R., Ren D., Zhang X., Su M.W.-C., Burakoff S.J., and Jin Y.-J. Lipid raft distribution of CD4 depends on its palmitoylation and association with lck, and evidence for CD4-induced lipid raft aggregation as an additional mechanism to enhance CD3 signaling. J. Immunol. 170 (2003) 913
14. Crise B., and Rose J. Identification of palmitoylation sites on CD4, the human immunodeficiency virus receptor. J. Biol. Chem. 267 (1992) 13593
15. Kim P.W., Sun Z.-Y.J., Blacklow S.C., Wagner G., and Eck M.J. A zinc clasp structure tethers Lck to T cell co-receptors CD4 and CD8. Science 301 (2003) 1725
16. Lin R.S., Rodriguez C., Veillette A., and Lodish H.F. Zinc is essential for binding of p56lck to CD4 and CD8alpha. J. Biol. Chem. 273 (1998) 32878
17. 2+ ion links the cytoplasmic tail of CD4 and the N-terminal region of Lck. J. Biol. Chem. 273 (1998) 18729
18. Lewis L., Chung C., Chen J., Parnes J., Moran M., Patel V., and Miceli M. The Lck SH2 phosphotyrosine binding site is critical for efficient TCR-induced processive tyrosine phosphorylation of the zeta-chain and IL-2 production. J. Immunol. 159 (1997) 2292
19. Mustelin T., and Tasken K. Positive and negative regulation of T-cell activation through kinases and phosphatases. Biochem. J. 371 (2003) 15
20. Pelchen-Matthews A., Armes J.E., Griffiths G., and Marsh M. Differential endocytosis of CD4 in lymphocytic and nonlymphocytic cells. J. Exp. Med. 173 (1991) 575
21. Pond L., Kuhn L.A., Teyton L., Schutze M.-P., Tainer J.A., Jackson M.R., and Peterson P.A. A role for acidic residues in di-leucine motif-based targeting to the endocytic pathway. J. Biol. Chem. 270 (1995) 19989
22. Pitcher C., Honing S., Fingerhut A., Bowers K., and Marsh M. Cluster of differentiation antigen 4 (CD4) endocytosis and adaptor complex binding require activation of the endocytosis signal by serine phosphorylation. Mol. Biol. Cell 10 (1999) 677
23. Weyand C., Goronzy J., and Fathman C. Modulation of CD4 by antigenic activation. J. Immunol. 138 (1987) 1351
24. Saggioro D., Sorio C., Calderazzo F., Callegaro L., Panozzo M., Berton G., and Chieco-Bianchi L. Mechanism of action of the monosialoganglioside GM1 as a modulator of CD4 expression. Evidence that GM1-CD4 interaction triggers dissociation of p56lck from CD4, and CD4 internalization and degradation [published erratum appears in J. Biol. Chem. 268 (8) (1993) 6064]. J. Biol. Chem. 268 (1993) 1368
25. Kim Y.-H., Chang S.H., Kwon J.H., and Rhee S.S. HIV-1 nef plays an essential role in two independent processes in CD4 down-regulation: dissociation of the CD4-p56lck complex and targeting of CD4 to lysosomes. Virology 257 (1999) 208
26. Strong J., Wang Q., and Killeen N. Impaired survival of T helper cells in the absence of CD4. Proc. Natl. Acad. Sci. USA 98 (2001) 2566
27. Biewenga G.P., Haenen G.R.M.M., and Bast A. The pharmacology of the antioxidant lipoic acid. Gen. Pharmacol. 29 (1997) 315
28. Estrada D., Ewart H., Tsakiridis T., Volchuk A., Ramlal T., Tritschler H., and Klip A. Stimulation of glucose uptake by the natural coenzyme alpha-lipoic acid/thioctic acid: participation of elements of the insulin signaling pathway. Diabetes 45 (1996) 1798
29. Cho K.-J., Moini H., Shon H.-K., Chung A.-S., and Packer L. [alpha]-Lipoic acid decreases thiol reactivity of the insulin receptor and protein tyrosine phosphatase 1B in 3T3-L1 adipocytes. Biochem. Pharmacol. 66 (2003) 849
30. Marracci G.H., Jones R.E., McKeon G.P., and Bourdette D.N. Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis. J. Neuroimmunol. 131 (2002) 104
31. Marracci G.H., McKeon G.P., Marquardt W.E., Winter R., Riscoe M., and Bourdette D.N. Alpha-lipoic acid inhibits human T-cell migration: implications for multiple sclerosis. J. Neurosci. Res. 78 (2004) 362-370
32. Sorice M., Pavan A., Misasi R., Sansolini T., Garofalo T., Lenti L., Pontieri G.M., Frati L., and Torrisi M.R. Monosialoganglioside GM3 induces CD4 internalization in human peripheral blood T lymphocytes. Scand J. Immunol. 41 (1995) 148
33. Pelchen-Matthews A., Parsons I.J., and Marsh M. Phorbol ester-induced downregulation of CD4 is a multistep process involving dissociation from p56lck, increased association with clathrin-coated pits, and altered endosomal sorting. J. Exp. Med. 178 (1993) 1209
34. Pelchen-Matthews A., Boulet I., Littman D.R., Fagard R., and Marsh M. The protein tyrosine kinase p56lck inhibits CD4 endocytosis by preventing entry of CD4 into coated pits. J. Cell. Biol. 117 (1992) 279
35. Sleckman B., Shin J., Igras V., Collins T., Strominger J., and Burakoff S. Disruption of the CD4-p56lck complex is required for rapid internalization of CD4. Proc. Natl. Acad. Sci. USA 89 (1992) 7566
36. + T lymphocytes. J. Virol. 69 (1995) 5243
37. Schols D., Baba M., Pauwels R., Desmyter J., and De Clercq E. Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus/CD4 cell receptor. Proc. Natl. Acad. Sci. USA 86 (1989) 3322
38. Garcia J.V., and Miller A.D. Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature 350 (1991) 508
39. Rhee S.S., and Marsh J.W. Human immunodeficiency virus type 1 Nef-induced down-modulation of CD4 is due to rapid internalization and degradation of surface CD4. J. Virol. 68 (1994) 5156
40. Salghetti S., Mariani R., and Skowronski J. Human immunodeficiency virus type 1 nef and p56lck protein-tyrosine kinase interact with a common element in CD4 cytoplasmic tail. Proc. Natl. Acad. Sci. USA 92 (1995) 349
41. Offner H., Thieme T., and Vandenbark A.A. Gangliosides induce selective modulation of CD4 from helper T lymphocytes. J. Immunol. 139 (1987) 3295
42. Morrison W.J., Offner H., and Vandenbark A.A. Ganglioside (GM1)-treated T cells shed CD4. Immunopharmacology 22 (1991) 77
43. Packer L., Tritschler H.J., and Wessel K. Neuroprotection by the metabolic antioxidant alpha-lipoic acid. Free Radic. Biol. Med. 22 (1997) 359
44. Ghezzi P., Romines B., Fratelli M., Eberini I., Gianazza E., Casagrande S., Laragione T., Mengozzi M., Herzenberg L.A., and Herzenberg L.A. Protein glutathionylation: coupling and uncoupling of glutathione to protein thiol groups in lymphocytes under oxidative stress and HIV infection. Mol. Immunol. 38 (2002) 773
45. Reiter C., Kakavand B., Rieber E.P., Schattenkirchner M., Riethmuller G., and Kruger K. Treatment of rheumatoid arthritis with monoclonal CD4 antibody M-T151. Clinical results and immunopharmacologic effects in an open study, including repeated administration. Arthritis Rheum. 34 (1991) 525
46. Edling A.E., Choksi S., Huang Z., and Korngold R. Effect of a cyclic heptapeptide based on the human CD4 domain 1 CC' loop region on murine experimental allergic encephalomyelitis: inhibition of both primary and secondary responses. J. Neuroimmunol. 112 (2001) 115
47. + T cells in experimental autoimmune encephalomyelitis. Mult. Scler. 9 (2003) 579
48. Wang Q., Malherbe L., Zhang D., Zingler K., Glaichenhaus N., and Killeen N. CD4 promotes breadth in the TCR repertoire. J. Immunol. 167 (2001) 4311
49. Smith A.R., Shenvi S.V., Widlansky M., Suh J.H., and Hagen T.M. Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress. Curr. Med. Chem. 11 (2004) 1135